Additionally, in a previous meta-analysis study by Salvo et al. of hormone receptor-positive and HER2-negative breast cancers, it was confirmed that lymph-node positivity was an important factor for recurrence [31]. This evidence concerns the gene ERBB2 and breast carcinoma.